Development of a new and reliable assay for choline kinase using 31P NMR

Choline kinase catalyzes the conversion of choline to phosphocholine (PC) by transferring a phosphate group from adenosine triphosphate (ATP) as the first step in the biosynthetic pathway for the membrane phospholipid phosphatidylcholine, an essential pathway in the Leishmania parasitic protozoan. C...

Full description

Bibliographic Details
Main Authors: Jacob A. Walker, Joshua D. Friesen, Steven J. Peters, Marjorie A. Jones, Jon A. Friesen
Format: Article
Language:English
Published: Elsevier 2019-10-01
Series:Heliyon
Subjects:
TBC
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844019362450
id doaj-2a71380d99824540b4e840c2810c3c0b
record_format Article
spelling doaj-2a71380d99824540b4e840c2810c3c0b2020-11-25T02:56:36ZengElsevierHeliyon2405-84402019-10-01510e02585Development of a new and reliable assay for choline kinase using 31P NMRJacob A. Walker0Joshua D. Friesen1Steven J. Peters2Marjorie A. Jones3Jon A. Friesen4Department of Chemistry, Illinois State University, Normal, IL, 61790, United StatesDepartment of Chemistry, Illinois State University, Normal, IL, 61790, United StatesDepartment of Chemistry, Illinois State University, Normal, IL, 61790, United StatesDepartment of Chemistry, Illinois State University, Normal, IL, 61790, United StatesCorresponding author.; Department of Chemistry, Illinois State University, Normal, IL, 61790, United StatesCholine kinase catalyzes the conversion of choline to phosphocholine (PC) by transferring a phosphate group from adenosine triphosphate (ATP) as the first step in the biosynthetic pathway for the membrane phospholipid phosphatidylcholine, an essential pathway in the Leishmania parasitic protozoan. Commonly used methods for kinetically quantifying the enzyme include a radioisotope assay utilizing labeled choline and a coupled spectrophotometric assay with multiple enzymes and substrates that indirectly measures choline kinase activity. When testing potential inhibitors with the coupled assay, results can cast doubt on whether choline kinase is being inhibited or one of the coupled enzymes. Therefore, 31P NMR spectroscopy was used to quantitatively measure the formation of the key product, phosphocholine, and to evaluate choline kinase activity. Interrogation of 31P NMR spectroscopy offers a number of benefits. Since this isotope is 100% abundant and has a relatively large gyromagnetic ratio, it is considered one of the more sensitive nuclides. As such, the need for costly isotopic enriched phosphorous is not required and detection of the 31P signal is possible even at relatively low concentrations. The enzymatic activity of Leishmania infantum choline kinase was able to be directly measured via integration of the 31P resonance associated with the phosphocholine product (δ = 3.94 ppm). These initial studies reveal that a 31P NMR spectroscopic-based assay could be used for testing substrate or transition state analogs as competitive inhibitors of Leishmania choline kinase that may prevent phosphatidylcholine synthesis in the parasite.http://www.sciencedirect.com/science/article/pii/S2405844019362450TBC31P NMRCholineKinaseLeishmaniasisEnzyme
collection DOAJ
language English
format Article
sources DOAJ
author Jacob A. Walker
Joshua D. Friesen
Steven J. Peters
Marjorie A. Jones
Jon A. Friesen
spellingShingle Jacob A. Walker
Joshua D. Friesen
Steven J. Peters
Marjorie A. Jones
Jon A. Friesen
Development of a new and reliable assay for choline kinase using 31P NMR
Heliyon
TBC
31P NMR
Choline
Kinase
Leishmaniasis
Enzyme
author_facet Jacob A. Walker
Joshua D. Friesen
Steven J. Peters
Marjorie A. Jones
Jon A. Friesen
author_sort Jacob A. Walker
title Development of a new and reliable assay for choline kinase using 31P NMR
title_short Development of a new and reliable assay for choline kinase using 31P NMR
title_full Development of a new and reliable assay for choline kinase using 31P NMR
title_fullStr Development of a new and reliable assay for choline kinase using 31P NMR
title_full_unstemmed Development of a new and reliable assay for choline kinase using 31P NMR
title_sort development of a new and reliable assay for choline kinase using 31p nmr
publisher Elsevier
series Heliyon
issn 2405-8440
publishDate 2019-10-01
description Choline kinase catalyzes the conversion of choline to phosphocholine (PC) by transferring a phosphate group from adenosine triphosphate (ATP) as the first step in the biosynthetic pathway for the membrane phospholipid phosphatidylcholine, an essential pathway in the Leishmania parasitic protozoan. Commonly used methods for kinetically quantifying the enzyme include a radioisotope assay utilizing labeled choline and a coupled spectrophotometric assay with multiple enzymes and substrates that indirectly measures choline kinase activity. When testing potential inhibitors with the coupled assay, results can cast doubt on whether choline kinase is being inhibited or one of the coupled enzymes. Therefore, 31P NMR spectroscopy was used to quantitatively measure the formation of the key product, phosphocholine, and to evaluate choline kinase activity. Interrogation of 31P NMR spectroscopy offers a number of benefits. Since this isotope is 100% abundant and has a relatively large gyromagnetic ratio, it is considered one of the more sensitive nuclides. As such, the need for costly isotopic enriched phosphorous is not required and detection of the 31P signal is possible even at relatively low concentrations. The enzymatic activity of Leishmania infantum choline kinase was able to be directly measured via integration of the 31P resonance associated with the phosphocholine product (δ = 3.94 ppm). These initial studies reveal that a 31P NMR spectroscopic-based assay could be used for testing substrate or transition state analogs as competitive inhibitors of Leishmania choline kinase that may prevent phosphatidylcholine synthesis in the parasite.
topic TBC
31P NMR
Choline
Kinase
Leishmaniasis
Enzyme
url http://www.sciencedirect.com/science/article/pii/S2405844019362450
work_keys_str_mv AT jacobawalker developmentofanewandreliableassayforcholinekinaseusing31pnmr
AT joshuadfriesen developmentofanewandreliableassayforcholinekinaseusing31pnmr
AT stevenjpeters developmentofanewandreliableassayforcholinekinaseusing31pnmr
AT marjorieajones developmentofanewandreliableassayforcholinekinaseusing31pnmr
AT jonafriesen developmentofanewandreliableassayforcholinekinaseusing31pnmr
_version_ 1724713239735959552